About
Greenstreet is a physician. Alnylam's leadership page says she earned a medical degree from the University of Leeds and holds an MBA from INSEAD. According to the proxy statement she worked for 18 years at GlaxoSmithKline, then was head of Medicines Development at Pfizer from December 2010 to November 2013, and founded Highgate LLC in 2014. She joined Alnylam as chief operating officer in September 2016. Other pharmaceutical leaders with pages on Whoo include Vas Narasimhan of Novartis and Pascal Soriot of AstraZeneca.
Whoo compiled this page from public sources: Alnylam third-quarter 2026 results release (SEC), Alnylam 2026 proxy statement (SEC), Alnylam leadership page, Wikipedia. It is not affiliated with or endorsed by Yvonne Greenstreet. Are you Yvonne Greenstreet? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
Chief Executive Officer — Alnylam Pharmaceuticals
January 2022 – Present
- Board member since October 2021
- Worked there for 18 years; most recently Senior Vice President and Chief of Strategy for Research and Development
President and Chief Operating Officer — Alnylam Pharmaceuticals
October 2020 – January 2022
Chief Operating Officer — Alnylam Pharmaceuticals
September 2016 – October 2020
Founder and Managing Director — Highgate LLC
January 2014 – August 2016
Senior Vice President and Head of Medicines Development — Pfizer
December 2010 – November 2013